If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Maria Pia Pistillo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization

Mastracci, L., Fontana, V., Queirolo, P., Carosio, R., Grillo, F., Morabito, A., Banelli, B., Tanda, E., Boutros, A., Dozin, B., Gualco, M., Salvi, S., Romani, M., Spagnolo, F., Poggi, A. & Pistillo, M. P., Jan 1 2020, (Accepted/In press) In : Cancer Immunology, Immunotherapy.

Research output: Contribution to journalArticle

  • Determination of mesothelin levels in pleural effusion does not help predict survival of patients with malignant pleural mesothelioma

    Fontana, V., Pistillo, M. P. I. A., Vigani, A., Canessa, P. A., Berisso, G., Giannoni, U., Ferro, P., Franceschini, M. C., Carosio, R., Tonarelli, M., Rossi, C., Dessanti, P. & Roncella, S., Jan 1 2019, In : Anticancer Research. 39, 9, p. 5219-5223 5 p.

    Research output: Contribution to journalArticle

  • Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study: Cancer Immunology, Immunotherapy

    Pistillo, M. P., Fontana, V., Morabito, A., Dozin, B., Laurent, S., Carosio, R., Banelli, B., Ferrero, F., Spano, L., Tanda, E., Ferrucci, P. F., Martinoli, C., Cocorocchio, E., Guida, M., Tommasi, S., De Galitiis, F., Pagani, E., Antonini Cappellini, G. C., Marchetti, P., Quaglino, P. & 9 others, Fava, P., Osella-Abate, S., Ascierto, P. A., Capone, M., Simeone, E., Romani, M., Spagnolo, F., Queirolo, P. & (IMI), O. B. O. T. I. M. I., 2019, In : Cancer Immunol. Immunother.. 68, 1, p. 97-107 11 p.

    Research output: Contribution to journalArticle

  • Targeting of histone demethylases KDM5A and KDM6B inhibits the proliferation of temozolomide-resistant glioblastoma cells

    Romani, M., Daga, A., Banelli, B., Forlani, A. & Pistillo, M. P., Jun 1 2019, In : Cancers. 11, 6, 878.

    Research output: Contribution to journalArticle

    Open Access